Hong Kong, masanin ilimin halittar jiki na kasar Sin yana ba da haske da yawa game da omicoron da matakan rigakafi

Source: Farfesa na Tattalin Arziki
A ranar 24 ga Nuwamba, masanin ilimin halittu kuma Farfesa na Makarantar Kimiyyar Halittu, Jami'ar Hong Kong Li Ka Shing Faculty of Medicine, Dong-Yan Jin, DeepMed ya yi hira da shi kuma ya ba da haske da yawa game da Omicron da matakan rigakafin annoba.

Yanzu za mu iya samun tabbataccen ƙarshe daga binciken Omicron, cewa an halicce shi a zahiri don dacewa da yanayin da jikin ɗan adam ke da juriya.
Tushen tsira shi ne cewa jikin ɗan adam ya riga yana da rigakafi, don haka dole ne a rage ƙwayar cuta ta asali.Hakanan za'a iya cewa yana rage cututtukan cututtuka a matsayin yanayi ko farashi don ƙara gudun hijira ta yadda zai iya girma da kuma yin kwafi a cikin mutanen da suka riga sun kasance masu rigakafi.Don haka zai haifar da ci gaba da cututtuka, wato masu yin allurar har yanzu za su kamu da cutar, don haka a 2021 idan aka yi wa kowa allurar rigakafi kuma yana da ƙwayoyin rigakafi, zai zama mafi girma.Idan akasarin al'ummar duniya ba a yi musu alluran rigakafi ba kuma ba su kamu da cutar ba, har yanzu babbar matsalar za ta kasance Delta.
②
Yawancin mutanen da suka kamu da Omicron suna da alamun bayyanar cututtuka irin na mura waɗanda galibi suna shafar sashin numfashi na sama kuma ba a iya bambanta su da mura da mura.Ba tare da gwajin antigen ko nucleic acid ba, ya zama da wahala a iya bambanta tsakanin neocoronavirus, ƙwayar mura ko wasu cututtukan rhinovirus ko cututtukan coronavirus waɗanda ke haifar da mura.Adadin cututtukan asymptomatic da ƙananan lokuta na Omicron sun fi girma sosai, suna lissafin sama da 99.5% na jimlar cututtuka.
③
Cutar Neocoronavirus cuta ce mai iyakancewa, mai warkar da kai.Yanzu ga mafi yawan mutane, 99.6% ko fiye, yana da iyakacin kai da warkar da kai.
④
Ba wai cewa allurar ba ta da wani tasiri, illa dai allurar a gefe guda na iya rage kamuwa da cuta, a daya bangaren kuma, ko da ba ta hana kamuwa da cuta ba, tana iya taka muhimmiyar rawa wajen hana kamuwa da cututtuka masu tsanani da kuma rage kamuwa da cutar. na kwayar cutar ga wasu.Koyaya, ana amfani da mu don ganin tasirin allurar gabaɗaya ko ba komai, ko dai hana kamuwa da cuta gaba ɗaya ko gaba ɗaya kamar ba a ba da allurar rigakafi ba, kuma rahotanni da yawa har ma da fassarorin ƙwararru suna ba da ra'ayi mara kyau na rashin fahimta da fahimtar tasirin kariya da yawa. na alluran rigakafi.
⑤
Idan aka yi la’akari da bayanan bullar cutar a Hong Kong a bana, idan har ba a ba da allurar rigakafin guda daya ba, adadin mace-macen ya kai kashi 2.32%;idan an ba da harbi biyu na Coxin, shine 0.36%;harbi biyu na Fupirtide, shine 0.06%, wato, shida cikin dubu goma;idan an haɗu da harbi biyu na Coxin da harbi ɗaya na Fupirtide, shine 0.04%;idan an ba da harbi uku na Coxin, yana da 0.14%, wanda ke kusa da yawan mace-mace na mura;Shots hudu na Coxin, shine 0.11%.

Ya zuwa yanzu, sabon coronavirus ya wanzu kusan shekaru uku, mun haɓaka daga farkon gwajin nucleic acid zuwa gwajin antigen na yanzu, yana da matukar dacewa ga 'yan ƙasa don aiwatar da sabon gwajin coronavirus, kamfaninmu a halin yanzu yana da ya fi kowanucleic acid gwajin swabakan kasuwa, ana iya adana shi a samfuran ƙwayoyin cuta na ɗaki, da kuma sabon sabbin abubuwan gwajin antigen na coronavirus, mintuna 15 don samar da sakamako, samfuri mai sauƙi.
Kamfaninmu yana sanye da kayan aikin ganowa na PCR da nucleic acid ƙwararre a cikin gano Neocoronavirus, kuma kayan aikin haƙar acid nucleic na tashoshi 96 yana haɓaka saurin ganowa!Tuntube mu idan kuna buƙata.